camptothecin has been researched along with quinine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Agarwal, SM; Avecilla, F; Azam, A; Chen, CT; Heslop, DC; Inam, A; Salahuddin, A; van Zyl, RL | 1 |
| Bero, J; Frédérich, M; Leverrier, A; Palermo, J; Quetin-Leclercq, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bero, J; Cabrera, J; Frédérich, M; Leverrier, A; Palermo, JA; Quetin-Leclercq, J | 1 |
| Ahmad, K; Ansari, MF; Azam, A; Coetzee, M; Hayat, F; Inam, A; Kathrada, F; Shin, D; van Zyl, RL | 1 |
| Ademola, IK; Gordon, M; Karpoormath, R; Kayamba, F; Kushwaha, ND; Mahlalela, M; Malimabe, T; Mudau, PT; Nyamori, VO; Pooe, OJ; Shonhai, A; van Zyl, RL; Zininga, T | 1 |
9 other study(ies) available for camptothecin and quinine
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Synthesis and evaluation of 7-chloro-4-(piperazin-1-yl)quinoline-sulfonamide as hybrid antiprotozoal agents.
Topics: Amino Acid Sequence; Antiprotozoal Agents; Cell Survival; Chloroquine; Crystallography, X-Ray; Dihydropteroate Synthase; Drug Resistance; Entamoeba histolytica; Erythrocytes; Hemeproteins; Hemolysis; Humans; Molecular Docking Simulation; Molecular Sequence Data; Piperazines; Plasmodium falciparum; Protozoan Proteins; Quinine; Quinolines; Structure-Activity Relationship | 2013 |
Antiparasitic hybrids of Cinchona alkaloids and bile acids.
Topics: Antiparasitic Agents; Bile Acids and Salts; Cell Line; Cinchona Alkaloids; Humans; Inhibitory Concentration 50 | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Structure-activity relationship of hybrids of Cinchona alkaloids and bile acids with in vitro antiplasmodial and antitrypanosomal activities.
Topics: Antimalarials; Bile Acids and Salts; Cinchona Alkaloids; Dose-Response Relationship, Drug; Molecular Conformation; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2015 |
New antiprotozoal agents: Synthesis and biological evaluation of different 4-(7-chloroquinolin-4-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone derivatives.
Topics: Antimalarials; Antiprotozoal Agents; Binding Sites; Cell Line; Cell Survival; Chloroquine; Entamoeba histolytica; Erythrocytes; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Piperazine; Piperazines; Plasmodium falciparum; Protein Structure, Tertiary; Protozoan Proteins; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2017 |
Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors.
Topics: Antimalarials; Cell Survival; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimidines; Quinolines; Structure-Activity Relationship; Thermodynamics | 2021 |